NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/14/2025
Back to search
Official data from USPTO
PHARMACO-NET
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
10/14/2025
Trademark type
Combined
Nice classes
42
Filing date
10/25/2022
Registration date
10/14/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/14/2025
Last transaction
10/14/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
3
Owner type
03
Owner location
Daejeon, KR
Examiner
MCNAMARA, SHANA MARIE
Law office
N70
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized word "PHARMACO-NET" with a large capital "P". To the left of the word is a circuit pattern.
Holders and representatives
Holders
Calici Co., Ltd.
Representatives
Leigh Ann Lindquist Sughrue Mion, PLLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Drug discovery services; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical research and development; development of new technology for others in the field of biotechnology; research and development of technology for biotechnology; writing of computer programs for biotechnological applications; consulting services in the field of biotechnology; providing information on the subject of pharmaceutical testinginspectionresearch; computer programming in the medical field; research and development of amino acid for medical purpose; research and development of peptide for medical purposes; research and development of vaccines and medicines; development and creation of computer programmes for data processing; providing platform as a service (PAAS) services featuring computer software platforms for new drug candidates searching; design and development of computer software; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; development of software TO BE USED IN SOFTWARE AS A service (SAAS) services featuring software using artificial intelligence for new pharmaceuticals; development of software to be used in software as a service (SAAS) services featuring software using artificial intelligence for new drug candidates searching
Publications
History of USPTO decisions and trademark events.
43 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/14/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/26/2025
PUBO
PUBLISHED FOR OPPOSITION
08/26/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/20/2025
OTHE
CASE RETURNED TO EXAMINATION
08/05/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
08/05/2025
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
07/28/2025
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
07/28/2025
APET
ASSIGNED TO PETITION STAFF
07/28/2025
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
06/09/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/12/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/12/2025
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
05/12/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/12/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/12/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/12/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/12/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/06/2025
EX2G
SOU EXTENSION 2 GRANTED
03/05/2025
EXT2
SOU EXTENSION 2 FILED
03/05/2025
EEXT
SOU TEAS EXTENSION RECEIVED
03/05/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/04/2024
EX1G
SOU EXTENSION 1 GRANTED
09/04/2024
EXT1
SOU EXTENSION 1 FILED
09/04/2024
EEXT
SOU TEAS EXTENSION RECEIVED
09/04/2024
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
04/30/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/05/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/09/2024
PUBO
PUBLISHED FOR OPPOSITION
01/09/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/20/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/05/2023
DOCK
ASSIGNED TO EXAMINER
11/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/04/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/03/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/03/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/12/2023
GNRT
NON-FINAL ACTION E-MAILED
08/12/2023
CNRT
NON-FINAL ACTION WRITTEN
08/12/2023
DOCK
ASSIGNED TO EXAMINER
08/08/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/09/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/08/2022
NWAP
NEW APPLICATION ENTERED
10/28/2022
Continuous trademark protection
Get notified about every new filing that threatens PHARMACO-NET or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.